Page last updated: 2024-12-07

2,4,6-tripyridyl-s-triazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,4,6-Tripyridyl-s-triazine (TPT) is a nitrogen-containing heterocyclic compound that has garnered significant attention due to its versatility in diverse fields, including coordination chemistry, organic electronics, and materials science. Its synthesis typically involves the condensation reaction of pyridine with cyanuric chloride under basic conditions. TPT's structure features a central triazine ring with three pyridine rings attached, resulting in a rigid and planar molecule. This structural characteristic contributes to TPT's ability to form strong coordination bonds with various metal ions, making it a valuable ligand in the construction of metal-organic frameworks (MOFs), coordination polymers, and other coordination complexes. TPT complexes have found applications in luminescence, catalysis, and sensing. TPT itself exhibits interesting photophysical properties, including fluorescence, which has made it a subject of study in organic light-emitting diodes (OLEDs). The ability of TPT to form complexes with various metal ions, along with its photophysical properties, has led to its exploration for applications in areas such as energy storage, solar energy harvesting, and sensing. The unique combination of properties exhibited by TPT has positioned it as a valuable building block for the development of advanced materials with tailored functionalities.'

2,4,6-tripyridyl-s-triazine: color reagent for serum iron; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID77258
CHEMBL ID1450775
SCHEMBL ID322756
SCHEMBL ID17257399
MeSH IDM0043636

Synonyms (83)

Synonym
yg57d9p2vy ,
unii-yg57d9p2vy
5-26-19-00396 (beilstein handbook reference)
2,4,6-tri(2-pyridyl)-s-triazine
2,4,6-tripyridyl-s-triazine
tptz
2,6-tripyridyl-s-triazine
nsc-112125
tri-2-pyridyl-s-triazine
2,6-tri(2'-pyridyl)-s-triazine
1,5-triazine, 2,4,6-tri-2-pyridinyl-
s-triazine,4,6-tri-2-pyridyl-
2,6-tripyridyl-1,3,5-triazine
nsc112125
3682-35-7
2,6-tris(2-pyridyl)-1,3,5-triazine
s-triazine, tri-2-pyridyl-
tptz (iron reagent)
2,6-tris(2-pyridyl)-s-triazine
2,6-tris(2-pyridyl)-5-triazine
mls000737726 ,
2,6-tri(2-pyridyl)-s-triazine
terpyridyl-s-triazine
2,4,6-tris(2-pyridyl)-s-triazine, for spectrophotometric det. (of fe), >=98%
smr000444410
2,4,6-tris(2-pyridyl)-1,3,5-triazine
nsc 112125
2,4,6-tri-2-pyridinyl-1,3,5-triazine
1,3,5-triazine, 2,4,6-tri-2-pyridinyl-
2,4,6-tripyridyl-1,3,5-triazine
einecs 222-965-9
2,4,6-tris(2-pyridyl)-5-triazine
2,4,6-tris(2-pyridyl)-s-triazine
ai3-51067
s-triazine, 2,4,6-tri-2-pyridyl-
brn 0282581
T-7000
T0530
2,4,6-tri(2-pyridyl)-1,3,5-triazine
2,4,6-tripyridin-2-yl-1,3,5-triazine
HMS2792B08
AKOS004910369
NCGC00246952-01
FT-0609831
S10117
2,4,6-tris(2'-pyridyl)-1,3,5-triazine
tri(2-pyridinyl)-s-triazine
2,4,6-tri-.alpha.-pyridyl-1,3,5-triazine
2,4,6-tri-2-pyridinyl-s-triazine
2,4,6-tripyridyl-s-triazine [mi]
tris(pyridin-2-yl)-1,3,5-triazine
SCHEMBL322756
DTXSID7063132
2,4,6-tri(2-pyridyl)-1,3,5-triazine (tptz)
2,4,6-tri(2'-pyridyl)-s-triazine
2,4,6-tri(2-pyridinyl)-1,3,5-triazine #
2,4,6-tri-(2-pyridyl)-1,3,5-triazine
2,4,6-tripyridyl-sym-triazine
2,4,6-tris(2-pyridyl)-sym-triazine
KMVWNDHKTPHDMT-UHFFFAOYSA-N
2,4,6-tri-2-pyridyl-1,3,5-triazine
J-610025
2,4,6-tri-(2-pyridyl)-s-triazine
2,4,6-tris(2-pyridinyl)-1,3,5-triazine
bdbm52829
cid_77258
CHEMBL1450775
T-7001
SCHEMBL17257399
mfcd00006045
2,4,6-tris(2-pyridyl)-s-triazine, for spectrophotometric det. of fe, >=99.0%
2,4,6-tris(2-pyridyl)-s-triazine, 98%
2,4,6-tri(pyridin-2-yl)-1,3,5-triazine
SY012695
A855578
AS-18979
AMY23191
Q27294508
YSWG226
SB66976
2,4,6-tri(2-pyridyl)-1,3,5-triazine;2,4,6-tri(2-pyridyl)-1,3,5-triazine (tptz)
2,4,6-tripyridyl-s-triazine for spectrophotometric det. (of fe)
CS-0010133
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (14)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency15.84890.004023.8416100.0000AID485290
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency15.81140.140911.194039.8107AID2451
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency39.81070.177814.390939.8107AID2147
glp-1 receptor, partialHomo sapiens (human)Potency22.38720.01846.806014.1254AID624417
phosphopantetheinyl transferaseBacillus subtilisPotency100.00000.141337.9142100.0000AID1490
ATAD5 protein, partialHomo sapiens (human)Potency10.31830.004110.890331.5287AID504467
TDP1 proteinHomo sapiens (human)Potency16.46870.000811.382244.6684AID686978; AID686979
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency6.30960.707912.194339.8107AID720542
IDH1Homo sapiens (human)Potency29.09290.005210.865235.4813AID686970
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency89.12510.050127.073689.1251AID588590
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
short transient receptor potential channel 6 isoform 1Mus musculus (house mouse)EC50 (µMol)44.67000.020020.518970.7900AID2696
POsterior SegregationCaenorhabditis elegansEC50 (µMol)31.05402.201047.1808186.6810AID1964
Sodium-dependent noradrenaline transporter Homo sapiens (human)EC50 (µMol)54.57500.082031.0243168.9080AID1960
Zinc finger protein mex-5Caenorhabditis elegansEC50 (µMol)54.57500.082033.5679168.9080AID1960
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
monoamine transportSodium-dependent noradrenaline transporter Homo sapiens (human)
neurotransmitter transportSodium-dependent noradrenaline transporter Homo sapiens (human)
chemical synaptic transmissionSodium-dependent noradrenaline transporter Homo sapiens (human)
response to xenobiotic stimulusSodium-dependent noradrenaline transporter Homo sapiens (human)
response to painSodium-dependent noradrenaline transporter Homo sapiens (human)
norepinephrine uptakeSodium-dependent noradrenaline transporter Homo sapiens (human)
neuron cellular homeostasisSodium-dependent noradrenaline transporter Homo sapiens (human)
amino acid transportSodium-dependent noradrenaline transporter Homo sapiens (human)
norepinephrine transportSodium-dependent noradrenaline transporter Homo sapiens (human)
dopamine uptake involved in synaptic transmissionSodium-dependent noradrenaline transporter Homo sapiens (human)
sodium ion transmembrane transportSodium-dependent noradrenaline transporter Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
actin bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
neurotransmitter transmembrane transporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
neurotransmitter:sodium symporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
dopamine:sodium symporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
norepinephrine:sodium symporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
protein bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
monoamine transmembrane transporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
alpha-tubulin bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
metal ion bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
beta-tubulin bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
plasma membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
cell surfaceSodium-dependent noradrenaline transporter Homo sapiens (human)
membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
neuronal cell body membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
presynaptic membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
plasma membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
axonSodium-dependent noradrenaline transporter Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (29.73)18.7374
1990's1 (2.70)18.2507
2000's8 (21.62)29.6817
2010's15 (40.54)24.3611
2020's2 (5.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.97 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index28.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.63%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.63%)4.05%
Observational0 (0.00%)0.25%
Other36 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]